ES8601704A1 - Un polipeptido sintetico - Google Patents

Un polipeptido sintetico

Info

Publication number
ES8601704A1
ES8601704A1 ES529683A ES529683A ES8601704A1 ES 8601704 A1 ES8601704 A1 ES 8601704A1 ES 529683 A ES529683 A ES 529683A ES 529683 A ES529683 A ES 529683A ES 8601704 A1 ES8601704 A1 ES 8601704A1
Authority
ES
Spain
Prior art keywords
oncoprotein
amino acid
determinant
synthetic
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529683A
Other languages
English (en)
Spanish (es)
Other versions
ES529683A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES529683A0 publication Critical patent/ES529683A0/es
Publication of ES8601704A1 publication Critical patent/ES8601704A1/es
Expired legal-status Critical Current

Links

Classifications

    • G01N33/57575—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES529683A 1983-02-14 1984-02-13 Un polipeptido sintetico Expired ES8601704A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46632983A 1983-02-14 1983-02-14

Publications (2)

Publication Number Publication Date
ES529683A0 ES529683A0 (es) 1985-11-16
ES8601704A1 true ES8601704A1 (es) 1985-11-16

Family

ID=23851346

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529683A Expired ES8601704A1 (es) 1983-02-14 1984-02-13 Un polipeptido sintetico

Country Status (12)

Country Link
EP (1) EP0119702A3 (ref)
JP (1) JPS60500716A (ref)
DE (1) DE3490048T1 (ref)
ES (1) ES8601704A1 (ref)
GR (1) GR79812B (ref)
IE (1) IE840286L (ref)
IL (1) IL70947A (ref)
NO (1) NO844099L (ref)
NZ (1) NZ207121A (ref)
PT (1) PT78077B (ref)
WO (1) WO1984003087A1 (ref)
ZA (1) ZA84617B (ref)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1219232A (en) * 1983-08-17 1987-03-17 Richard A. Lerner Polypeptide-induced monoclonal receptors to protein ligands
US5030565A (en) * 1983-08-17 1991-07-09 Scripps Clinic And Research Foundation Polypeptide-induced monoclonal receptors to protein ligands
US5733738A (en) * 1983-08-17 1998-03-31 Ligand Pharmaceuticals Polypeptide-induced monoclonal receptors to protein ligands
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4794168A (en) * 1984-04-24 1988-12-27 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
EP0177814A3 (en) * 1984-09-19 1987-12-02 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US4762706A (en) * 1984-10-17 1988-08-09 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US5443956A (en) * 1985-01-29 1995-08-22 Oncogene Science, Inc. Detection, quantitation and classification of RAS proteins in body fluids and tissues
US4898932A (en) * 1985-01-29 1990-02-06 E. I. Du Pont De Nemours And Company Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5028527A (en) * 1988-02-22 1991-07-02 Applied Bio Technology Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
US5081230A (en) * 1987-07-08 1992-01-14 E. I. Dupont Denemours And Company Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein
US6200764B1 (en) 1985-01-29 2001-03-13 Bayer Corporation Detection, quantitation and classification of ras proteins in body fluids and tissues
EP0203587A3 (en) * 1985-05-30 1989-08-09 F. Hoffmann-La Roche Ag Ras oncogene peptides and antibodies
EP0206065A3 (en) * 1985-06-27 1989-04-19 James R. Feramisco Method of detecting oncogene and proto-oncogene related proteins in extracellular biological fluids
EP0267275A4 (en) * 1986-05-21 1989-09-19 Cold Spring Harbor Lab DNA SEQUENCE, CODING FOR -I (ROS) ONCOGEN, CODED POLYPEPTIDES THEREOF AND DETECTING METHODS BASED THEREFORE.
US5320941A (en) * 1986-06-06 1994-06-14 Dallan Young DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
JPS6374492A (ja) * 1986-09-18 1988-04-04 Hiroshi Shiyuku モノクロ−ナル抗体
WO1990001701A1 (en) * 1988-08-12 1990-02-22 Progenx, Inc. Polypeptide-induced monoclonal receptors to protein ligands
US6365151B1 (en) 1996-01-19 2002-04-02 Philadelphia Health And Educational Corporation Cellular immunogens comprising cognate proto-oxogenes
GB0014870D0 (en) * 2000-06-16 2000-08-09 King S College London Peptides
US10533044B2 (en) * 2014-01-06 2020-01-14 The General Hospital Corporation Integrin Antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180499A (en) * 1971-01-27 1979-12-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4075194A (en) * 1976-12-09 1978-02-21 Yeda Research And Development Co., Ltd. Novel synthetic undecapeptide and clinical assay
US4410510A (en) * 1980-03-10 1983-10-18 Virginia Livingston-Wheeler Method for preparing a purified extraction residue fraction and its use in stimulating the immune response
US4406885A (en) * 1978-12-28 1983-09-27 Research Corporation Preparation of native oncornavirus envelope subunits and vaccines therefrom
SE447263B (sv) * 1979-04-20 1986-11-03 Bonnierfoeretagen Ab Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection

Also Published As

Publication number Publication date
ES529683A0 (es) 1985-11-16
NZ207121A (en) 1988-05-30
IL70947A0 (en) 1984-05-31
IE840286L (en) 1984-08-14
EP0119702A3 (en) 1988-01-07
PT78077B (en) 1986-03-20
JPS60500716A (ja) 1985-05-16
NO844099L (no) 1984-10-12
WO1984003087A1 (en) 1984-08-16
GR79812B (ref) 1984-10-31
PT78077A (en) 1984-03-01
IL70947A (en) 1987-11-30
EP0119702A2 (en) 1984-09-26
DE3490048T1 (de) 1985-07-11
ZA84617B (en) 1984-09-26

Similar Documents

Publication Publication Date Title
ES8601704A1 (es) Un polipeptido sintetico
Bastardo et al. Preparation and characterization of antisera to electrophoretically purified SA11 virus polypeptides
Osterhaus et al. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
BRPI9912177B8 (pt) epítopos de célula auxiliar t artificiais como imunoestimuladores para imunógenos de peptídeo sintéticos, imunógenos de peptídeo e método para a produção dos mesmos
CY1111831T1 (el) Παραγωγα ογκο-συναφους αντιγονου απο την οικογενεια mage και αλληλουχιες νουκλεϊνικου οξεος που κωδικοποιουν αυτα, που χρησιμοποιουνται για την παρασκευη πρωτεϊνων συντηξης και συνθεσεων για εμβολιασμο
FI83667C (fi) Foerfarande foer framstaellning av monoklonala antikroppar mot sporozoiter av eimeria tenella och foerfarande foer framstaellning av e.tenella-vaccin.
DE3588203D1 (de) Durch pre-S-Gen kodierte Hepatitis-B-Peptid-Immunogene, Vakzine, Diagnostika und synthetische Lipid-Bläschenträger
NO963120D0 (no) Monoklonale antistoffer som binder til tumorrejeksjons-antigenforlöperen MAGE-3, rekombinant MAGE-1, og MAGE-1 avledete immunogene peptider
FI93310B (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
JP3356280B2 (ja) 哺乳動物免疫不全ウイルスの検出
JPS58213723A (ja) 口蹄疫ウイルス抗原の特異性を有する小型ペプチド
CN1610697A (zh) 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途
Yamanishi et al. Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome
ES551461A0 (es) Un metodo para la preparacion de una vacuna parvovirus canina.
Stowring et al. Serological definition of the lentivirus group of retroviruses
JP2002534481A5 (ref)
JPS63115825A (ja) 中和糖タンパク質のペプチド
Clark et al. Efficacy and safety field trials of a recombinant DNA vaccine against feline leukemia virus infection
ES8800273A1 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
JPH01224397A (ja) Ｈｉｖ抗体を検出するための合成ペプチド及びその混合物
Versteegen et al. Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses
Sabara et al. Immunogenicity of a bovine rotavirus glycoprotein fragment
Boulay et al. Localization of immunoreactive regions in the beef heart adenine nucleotide carrier using rabbit antisera against the carboxyatractyloside-liganded and the sodium dodecyl sulfate denatured carrier forms
Cruz et al. Study of different coupling agents in the conjugation of a V3‐based synthetic MAP to carrier proteins
DE69122850T2 (de) Konformationsepitope des humanen Immundefizienzvirus-Hüllprotein-gp120